Similar articles

Abstract: Considering the surgical risk stratification for patients with severe calcific aortic stenosis (AS), transcatheter aortic valve replacement (TAVR) is a reliable alternative to surgical aortic valve replacement (SAVR) (Fan et al., 2020, 2021; Lee et al., 2021). Despite the favorable clinical benefits of TAVR, stroke remains a dreaded perioperative complication (Auffret et al., 2016; Kapadia et al., 2016; Kleiman et al., 2016; Huded et al., 2019). Ischemic overt stroke, identified in 1.4% to 4.3% of patients in TAVR clinical practice, has been associated with prolonged disability and increased mortality (Auffret et al., 2016; Kapadia et al., 2016; Levi et al., 2022). The prevalence of hyperintensity cerebral ischemic lesions detected by diffusion-weighted magnetic resonance imaging (DW-MRI) was reported to be about 80%, which is associated with impaired neurocognitive function and vascular dementia (Vermeer et al., 2003; Barber et al., 2008; Kahlert et al., 2010).

经导管主动脉瓣置换术治疗单纯主动脉瓣反流患者术后脑损伤

[1]AlharbiAA, KhanMZ, OsmanM, et al., 2020. Transcatheter aortic valve replacement vs surgical replacement in patients with pure aortic insufficiency. Mayo Clin Proc, 95(12):2655-2664.

[2]AmbroseJA, BaruaRS, 2004. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol, 43(10):1731-1737.

[3]AstarciP, GlineurD, KeferJ, et al., 2011. Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using edwards sapiens valve. Eur J Cardiothorac Surg, 40(2):475-479.

[4]AthappanG, GajulapalliRD, SengodanP, et al., 2014. Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature. J Am Coll Cardiol, 63(20):2101-2110.

[5]AuffretV, RegueiroA, del TrigoM, et al., 2016. Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement. J Am Coll Cardiol, 68(7):673-684.

[6]BarberPA, HachS, TippettLJ, et al., 2008. Cerebral ischemic lesions on diffusion-weighted imaging are associated with neurocognitive decline after cardiac surgery. Stroke, 39(5):1427-1433.

[7]BosmansJ, BleizifferS, GerckensU, et al., 2015. The incidence and predictors of early- and mid-term clinically relevant neurological events after transcatheter aortic valve replacement in real-world patients. J Am Coll Cardiol, 66(3):209-217.

[8]DaneaultB, KirtaneAJ, KodaliSK, et al., 2011. Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review. J Am Coll Cardiol, 58(21):2143-2150.

[9]DueringM, RighartR, CsanadiE, et al., 2012. Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology, 79(20):2025-2028.

[10]FairbairnTA, MatherAN, BijsterveldP, et al., 2012. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart, 98(1):18-23.

[11]FanJQ, FangX, LiuCH, et al., 2020. Brain injury after transcatheter replacement of bicuspid versus tricuspid aortic valves. J Am Coll Cardiol, 76(22):2579-2590.

[12]FanJQ, YuCJ, RenKD, et al., 2021. Kidney function change after transcatheter aortic valve replacement in patients with diabetes and/or hypertension. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(3):241-247.

[13]GhanemA, MüllerA, NähleCP, et al., 2010. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol, 55(14):1427-1432.

[14]GuoRK, XieMH, YimWY, et al., 2021. Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement. BMC Cardiovasc Disord, 21:358.

[15]HénonH, DurieuI, GuerouaouD, et al., 2001. Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology, 57(7):1216-1222.

[16]HenseyM, MurdochDJ, SathananthanJ, et al., 2019. First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system. EuroIntervention, 14(15):e1553-e1555.

[17]HiraRS, VemulapalliS, LiZK, et al., 2017. Trends and outcomes of off-label use of transcatheter aortic valve replacement: insights from the NCDR STS/ACC TVT registry. JAMA Cardiol, 2(8):846-854.

[18]HudedCP, TuzcuEM, KrishnaswamyA, et al., 2019. Association between transcatheter aortic valve replacement and early postprocedural stroke. JAMA, 321(23):2306-2315.

[19]IsogaiT, SaadAM, AhujaKR, et al., 2021. Short-term outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation in the United States. Catheter Cardiovasc Interv, 97(3):477-485.

[20]IungB, BaronG, ButchartEG, et al., 2003. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 24(13):1231-1243.

[21]KahlertP, KnippSC, SchlamannM, et al., 2010. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation, 121(7):870-878.

[22]KahlertP, Al-RashidF, DöttgerP, et al., 2012. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation, 126(10):1245-1255.

[23]KajioK, MizutaniK, HaraM, et al., 2019. Self-expandable transcatheter aortic valve replacement is associated with frequent periprocedural stroke detected by diffusion-weighted magnetic resonance imaging. J Cardiol, 74(1):27-33.

[24]KapadiaS, AgarwalS, MillerDC, et al., 2016. Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER trial (placement of aortic transcatheter valves). Circ Cardiovasc Interv, 9(9):e002981.

[25]KapadiaSR, KodaliS, MakkarR, et al., 2017. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol, 69(4):367-377.

[26]KleimanNS, MainiBJ, ReardonMJ, et al., 2016. Neurological events following transcatheter aortic valve replacement and their predictors: a report from the CoreValve trials. Circ Cardiovasc Interv, 9(9):e003551.

[27]KliperE, BashatDB, BornsteinNM, et al., 2013. Cognitive decline after stroke: relation to inflammatory biomarkers and hippocampal volume. Stroke, 44(5):1433-1435.

[28]LeeCH, InoharaT, HayashidaK, et al., 2021. Transcatheter aortic valve replacement in Asia: present status and future perspectives. JACC Asia, 1(3):279-293.

[29]LeviA, LinderM, SeiffertM, et al., 2022. Management and outcome of acute ischemic stroke complicating transcatheter aortic valve replacement. JACC Cardiovasc Interv, 15(18):1808-1819.

[30]MaurerG, 2006. Aortic regurgitation. Heart, 92(7):994-1000.

[31]MillerDC, BlackstoneEH, MackMJ, et al., 2012. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg, 143(4):832-843.e13.

[32]OmranH, SchmidtH, HackenbrochM, et al., 2003. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet, 361(9365):1241-1246.

[33]OttoCM, NishimuraRA, BonowRO, et al., 2021. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 77(4):450-500.

[34]PollariF, HitzlW, VogtF, et al., 2020. Aortic valve calcification as a risk factor for major complications and reduced survival after transcatheter replacement. J Cardiovasc Comput Tomogr, 14(4):307-313.

[35]RoyDA, SchaeferU, GuettaV, et al., 2013. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol, 61(15):1577-1584.

[36]SamimM, HendrikseJ, van der WorpHB, et al., 2015. Silent ischemic brain lesions after transcatheter aortic valve replacement: lesion distribution and predictors. Clin Res Cardiol, 104(5):430-438.

[37]SawayaFJ, DeutschMA, SeiffertM, et al., 2017. Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an international registry study. JACC Cardiovasc Interv, 10(10):1048-1056.

[38]SchäferU, SchirmerJ, NiklasS, et al., 2017. First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation. EuroIntervention, 13(11):1296-1299.

[39]SeiffertM, DiemertP, KoschykD, et al., 2013. Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc Interv, 6(6):590-597.

[40]ShiJ, WeiL, ChenYC, et al., 2021. Transcatheter aortic valve implantation with J-Valve: 2-year outcomes from a multicenter study. Ann Thorac Surg, 111(5):1530-1536.

[41]StachonP, KaierK, HeidtT, et al., 2020. Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008‒2015. Catheter Cardiovasc Interv, 95(4):810-816.

[42]TestaL, LatibA, RossiML, et al., 2014. Corevalve implantation for severe aortic regurgitation: a multicentre registry. EuroIntervention, 10(6):739-745.

[43]van MieghemNM, el FaquirN, RahhabZ, et al., 2015. Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation. JACC Cardiovasc Interv, 8(5):718-724.

[44]VermeerSE, PrinsND, den HeijerT, et al., 2003. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med, 348(13):1215-1222.

[45]WernlyB, EderS, NavareseEP, et al., 2019. Transcatheter aortic valve replacement for pure aortic valve regurgitation: “on-label” versus “off-label” use of TAVR devices. Clin Res Cardiol, 108(8):921-930.

[46]YoonSH, SchmidtT, BleizifferS, et al., 2017. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol, 70(22):2752-2763.